Drug intelligence / Profile preview

Pure PRP II

Development stage
Unknown
Lead developer
Emcyte
Modality
Cell Therapies
Administration
Injection, Topical
01

Overview

Pure PRP II is a specialized autologous platelet-rich plasma (PRP) preparation system developed by EmCyte Corporation. It is designed to concentrate high levels of platelets and regenerative growth factors from a patient's own peripheral blood while significantly reducing the presence of proinflammatory red blood cells and granulocytes. The system utilizes a unique concentrated biologic preparation process that allows for high platelet recovery yields (often exceeding 80%). Upon injection into damaged tissue, the concentrated platelets undergo degranulation, releasing essential signaling proteins such as Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-β), and Vascular Endothelial Growth Factor (VEGF). these factors collectively stimulate cellular proliferation, angiogenesis, and extracellular matrix synthesis, facilitating tissue repair and regeneration in orthopedic, sports medicine, and aesthetic applications.

Brand names
Pure PRP IIPurePRPPurePRP IIEmCyte PurePRP
Other names
autologous platelet-rich plasmaPRPplatelet-rich plasma

Beyond the preview

Go deeper on Pure PRP II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pure PRP II.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call